Microsoft
MSFT
Meta Platforms
META
Taiwan Semiconductor
TSM
4
Oracle
ORCL
5
Amazon
AMZN
US Stock MarketDetailed Quotes
ITOS ITeos Therapeutics
- 7.500
- +0.250+3.45%
Close May 1 16:00 ET
287.05MMarket Cap-2.46P/E (TTM)
7.560High7.265Low1.15MVolume7.270Open7.250Pre Close8.59MTurnover3.95%Turnover RatioLossP/E (Static)38.27MShares18.75052wk High0.51P/B219.20MFloat Cap4.80052wk Low--Dividend TTM29.23MShs Float52.430Historical High--Div YieldTTM4.07%Amplitude4.800Historical Low7.436Avg Price1Lot Size
About ITeos Therapeutics Company
iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a new generation of immuno-oncology therapeutics for people living with cancer. Its pipeline includes EOS-448, Inupadenant, and EOS-984. The company was founded by Michel Detheux in April 2012 and is headquartered in Watertown, MA.
Company Profile
SymbolITOS
Company NameITeos Therapeutics
Listing DateJul 24, 2020
Issue Price19.00
Founded2012
CEODr. Michel Detheux, PhD
MarketNASDAQ
Employees173
Fiscal Year Ends12-31
Address321 Arsenal Street
CityWatertown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02472
Phone1-339-217-0162
Company Executives
- Name
- Position
- Salary
- Dr. Michel Detheux, PhD
- President, Chief Executive Officer and Director
- 6.09M
- Matthew Gall
- Chief Financial Officer and Principal Accounting Officer
- --
- Matthew Call
- Chief Operating Officer
- 2.62M
- David Feltquate
- Chief Medical Officer
- --
- Dr. Yvonne McGrath
- Chief Scientific Officer
- --
- David L. Hallal
- Chairman of the Board
- 442.82K
- Jill DeSimone
- Independent Director
- 686.27K
- Ann D. Rhoads
- Independent Director
- 345.57K
- Tim Van Hauwermeiren, M. Sc.
- Independent Director
- 331.57K
- David K. Lee
- Independent Director
- 320.07K
- Dr. Tony Ho, M.D.
- Independent Director
- 332.76K
- Dr. Robert Iannone, M.D.
- Independent Director
- 341.26K
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call